The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
ATAGI urges all adult Sydneysiders to 'strongly consider' the AstraZeneca vaccine amid NSW COVID outbreak
https://www.abc.net.au/news/2021-07-24/atagi-says-anyone-over-18-should-get-astrazeneca/100321056
AstraZeneca wins China nod for lung cancer drug
July 19 AstraZeneca drug Imfinzi has been approved by Chinese regulators to treat extensive-stage small cell lung cancer in adults, the drugmaker said on Monday.
The FDA how is easy approved drug for USA company Biogen , Alzheimer’s Disease Drug Aduhelm but in the same time FDA is very hard with AstraZeneca
https://newyork.cbslocal.com/2021/07/15/alzheimers-disease-rug-aduhelm-mount-sinai-health-system-fda/
The FDA discriminate against AstraZeneca and they try to protect the Americans companies
https://www.hcplive.com/view/fda-committee-recommends-against-roxadustat-approval-cdk
J&J, AstraZeneca Explore Covid-19 Vaccine Modification in Response to Rare Blood Clots
https://www.wsj.com/articles/j-j-astrazeneca-explore-covid-19-vaccine-modification-in-response-to-rare-blood-clots-11626173015
AstraZeneca vaccine available to all adults, jabs mandated for aged care workers In Australia
https://www.smh.com.au/politics/federal/mandatory-vaccines-for-aged-care-workers-quarantine-to-be-separated-20210628-p5850h.html
For best results when printing this announcement, please click on link below: http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210607:nBw6stbJ3a&default-theme=true
Alexion Announces FDA Approval of ULTOMIRIS(®) (ravulizumab-cwvz) for
Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
– With this approval, ULTOMIRIS is the first and only medicine approved in the U.S. to treat children and adolescents with PNH –
– Approval based on interim results from Phase 3 study showing ULTOMIRIS demonstrated complete terminal complement inhibition through 26 weeks –
Alexion Pharmaceuticals, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.Alexion.com&esheet=52438916&newsitemid=20210607005638&lan=en-US&anchor=Alexion+Pharmaceuticals%2C+Inc.&index=1&md5=05f333336ecc7f127c1e74ba210a7076) (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of ULTOMIRIS(®) (ravulizumab-cwvz) to include children (one month of age and older) and adolescents with paroxysmal nocturnal hemoglobinuria (PNH). ULTOMIRIS, a long-acting C5 inhibitor that offers immediate, complete and sustained complement inhibition, is now the first and only FDA-approved medicine for children and adolescents with PNH.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210607005638/en/ (https://www.businesswire.com/news/home/20210607005638/en/)
Image of ULTOMIRIS® (ravulizumab-cwvz) 100 mg/mL vials (3 mL and 11 mL). (Photo: Business Wire)
“It can take months, and sometimes years, to receive a correct diagnosis for
PNH — a chronic, progressive and potentially life-threatening rare disease – which can be an overwhelming experience for children and their families,” said Satheesh Chonat, M.D., principal investigator for the pediatric clinical trial and pediatric hematologist and oncologist at the
AstraZeneca's Lynparza reduces relapse, death in breast cancer patients
https://www.reuters.com/article/us-astrazeneca-study/astrazenecas-lynparza-reduces-relapse-death-in-breast-cancer-patients-idUSKCN2DF2D8
This is great news for AstraZeneca .
Israel Finds Probable Link Between Pfizer Shot, Myocarditis
https://www.bloomberg.com/news/articles/2021-06-02/israel-finds-probable-link-between-pfizer-shot-and-myocarditis
Germany to allow AstraZeneca COVID-19 vaccine for all adults
https://www.reuters.com/world/europe/germany-allow-astrazeneca-covid-19-vaccine-all-adults-minister-2021-05-06/
https://www.sharecast.com/news/broker-recommendations/berenberg-stays-at-buy-on-astrazeneca-positive-on-antibody-treatment--7718375.html
Berenberg stays at 'buy' on AstraZeneca, positive on antibody treatment
EU says no decision yet on legal action against AstraZeneca
23 Apr 2021 01:21
BRUSSELS, April 22 (Reuters) – The European Commission said on Wednesday no decision had yet been taken on whether to launch legal action against AstraZeneca after Ireland's Health
Minister said the case had been initiated. ...
"No decision to launch legal actions has been taken at this point in time," a spokesman for the Commission said.